Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer
Clinical trial NCT05617040 · TERMINATED
Trial details
- NCT number
- NCT05617040
- Sponsor
- Barinthus Biotherapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-30
- Primary completion
- 2025-02-05
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.